CA2683578A1 - A transition metal catalyzed synthesis of n-aminoindoles - Google Patents

A transition metal catalyzed synthesis of n-aminoindoles Download PDF

Info

Publication number
CA2683578A1
CA2683578A1 CA002683578A CA2683578A CA2683578A1 CA 2683578 A1 CA2683578 A1 CA 2683578A1 CA 002683578 A CA002683578 A CA 002683578A CA 2683578 A CA2683578 A CA 2683578A CA 2683578 A1 CA2683578 A1 CA 2683578A1
Authority
CA
Canada
Prior art keywords
unsubstituted
another
mono
alkyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002683578A
Other languages
English (en)
French (fr)
Inventor
Nis Halland
M. Nazare
Andreas Lindenschmidt
Omar Rkyek
Matthias Urmann
Jorge Alonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2683578A1 publication Critical patent/CA2683578A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002683578A 2007-04-13 2008-03-29 A transition metal catalyzed synthesis of n-aminoindoles Abandoned CA2683578A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07007585.8 2007-04-13
EP07007585 2007-04-13
PCT/EP2008/002519 WO2008125207A1 (en) 2007-04-13 2008-03-29 A transition metal catalyzed synthesis of n-aminoindoles

Publications (1)

Publication Number Publication Date
CA2683578A1 true CA2683578A1 (en) 2008-10-23

Family

ID=38457866

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002683578A Abandoned CA2683578A1 (en) 2007-04-13 2008-03-29 A transition metal catalyzed synthesis of n-aminoindoles

Country Status (12)

Country Link
US (1) US8026375B2 (https=)
EP (1) EP2134682B1 (https=)
JP (1) JP5412422B2 (https=)
KR (1) KR20100015546A (https=)
CN (1) CN101657422A (https=)
AT (1) ATE537142T1 (https=)
AU (1) AU2008238379A1 (https=)
BR (1) BRPI0810199A2 (https=)
CA (1) CA2683578A1 (https=)
IL (1) IL201253A0 (https=)
MX (1) MX2009010536A (https=)
WO (1) WO2008125207A1 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1831225A2 (en) 2004-11-19 2007-09-12 The Regents of the University of California Anti-inflammatory pyrazolopyrimidines
WO2007114926A2 (en) 2006-04-04 2007-10-11 The Regents Of The University Of California Kinase antagonists
GB2467670B (en) 2007-10-04 2012-08-01 Intellikine Inc Chemical entities and therapeutic uses thereof
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
MX2010007419A (es) 2008-01-04 2010-11-12 Intellikine Inc Ciertas entidades quimicas, composiciones y metodos.
US8993580B2 (en) 2008-03-14 2015-03-31 Intellikine Llc Benzothiazole kinase inhibitors and methods of use
EP2252293B1 (en) 2008-03-14 2018-06-27 Intellikine, LLC Kinase inhibitors and methods of use
US20110224223A1 (en) 2008-07-08 2011-09-15 The Regents Of The University Of California, A California Corporation MTOR Modulators and Uses Thereof
BRPI0915231A2 (pt) 2008-07-08 2018-06-12 Intellikine Inc compostos inibidores de quinase e métodos de uso
CA2738429C (en) 2008-09-26 2016-10-25 Intellikine, Inc. Heterocyclic kinase inhibitors
EP2358720B1 (en) 2008-10-16 2016-03-02 The Regents of The University of California Fused ring heteroaryl kinase inhibitors
US8476431B2 (en) 2008-11-03 2013-07-02 Itellikine LLC Benzoxazole kinase inhibitors and methods of use
JP5789252B2 (ja) 2009-05-07 2015-10-07 インテリカイン, エルエルシー 複素環式化合物およびその使用
WO2011047384A2 (en) 2009-10-16 2011-04-21 The Regents Of The University Of California Methods of inhibiting ire1
CA2799579A1 (en) 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
JP2013545749A (ja) 2010-11-10 2013-12-26 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環化合物及びその使用
ES2637113T3 (es) 2011-01-10 2017-10-10 Infinity Pharmaceuticals, Inc. Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
CN102093334B (zh) * 2011-02-22 2013-05-08 郑州大学 一组稠环噻吩类化合物的合成方法
US9295673B2 (en) 2011-02-23 2016-03-29 Intellikine Llc Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
HK1198443A1 (en) 2011-07-19 2015-04-24 无限药品股份有限公司 Heterocyclic compounds and uses thereof
AR088218A1 (es) 2011-07-19 2014-05-21 Infinity Pharmaceuticals Inc Compuestos heterociclicos utiles como inhibidores de pi3k
MX2014002542A (es) 2011-08-29 2014-07-09 Infinity Pharmaceuticals Inc Compuestos heterociclicos y usos de los mismos.
CA2846496C (en) 2011-09-02 2020-07-14 The Regents Of The University Of California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
JP2015532287A (ja) 2012-09-26 2015-11-09 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ire1の調節
AU2013337717B2 (en) 2012-11-01 2018-10-25 Infinity Pharmaceuticals, Inc. Treatment of cancers using PI3 kinase isoform modulators
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
PT3052485T (pt) 2013-10-04 2021-10-22 Infinity Pharmaceuticals Inc Compostos heterocíclicos e suas utilizações
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN103755621B (zh) * 2014-01-23 2015-08-05 清华大学 由芳基肼和炔烃制备多取代吲哚的方法
MX382033B (es) 2014-03-19 2025-03-13 Infinity Pharmaceuticals Inc Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2016069796A1 (en) * 2014-10-28 2016-05-06 Spectrum Spine Ip Holdings, Llc Expandable, adjustable inter-body fusion devices and methods
WO2017048702A1 (en) 2015-09-14 2017-03-23 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201811237WA (en) 2016-06-24 2019-01-30 Infinity Pharmaceuticals Inc Combination therapies
KR102038977B1 (ko) * 2016-12-30 2019-11-01 사빅 에스케이 넥슬렌 컴퍼니 피티이 엘티디 신규한 시클로펜타[b]티오펜일 전이금속 화합물, 이를 포함하는 전이금속 촉매 조성물, 및 이를 이용한 에틸렌 단독중합체 또는 에틸렌과 α-올레핀의 공중합체의 제조방법
WO2020132384A1 (en) 2018-12-21 2020-06-25 Celgene Corporation Thienopyridine inhibitors of ripk2
EP3898725B1 (en) * 2018-12-21 2025-10-01 Dow Global Technologies LLC Heterocycle-heterocycle-based group iv transition metal catalysts for olefin polymerization
CN116813522A (zh) * 2023-05-04 2023-09-29 广州方中化工有限公司 一种含吲哚的苯磺酰脲类化合物的制备方法与应用
CN118638038B (zh) * 2024-06-05 2024-12-03 常州大学 一种n-n轴手性吲哚酰胺类化合物及其合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287982B1 (en) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US4983608A (en) 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
EP1035114B1 (en) 1999-03-10 2004-11-24 Tosoh Corporation Processes for the preparation of nitrogen-heterocyclic compounds
FR2842196B1 (fr) * 2002-07-15 2006-01-13 Rhodia Polyamide Intermediates Procede de fabrication de composes nitriles a partir de composes a insaturation ethylenique
EP2119455A1 (en) 2004-04-08 2009-11-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tripartite raftophilic structures and their use

Also Published As

Publication number Publication date
WO2008125207A1 (en) 2008-10-23
AU2008238379A1 (en) 2008-10-23
US8026375B2 (en) 2011-09-27
KR20100015546A (ko) 2010-02-12
EP2134682A1 (en) 2009-12-23
IL201253A0 (en) 2010-05-31
CN101657422A (zh) 2010-02-24
US20100168429A1 (en) 2010-07-01
JP5412422B2 (ja) 2014-02-12
MX2009010536A (es) 2009-10-22
EP2134682B1 (en) 2011-12-14
JP2010523605A (ja) 2010-07-15
BRPI0810199A2 (pt) 2014-10-14
ATE537142T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
EP2134682B1 (en) A transition metal catalyzed synthesis of n-aminoindoles
EP2170833B1 (en) A transition metal catalyzed synthesis of 2h-indazoles
US8188282B2 (en) Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
EP2173747B1 (en) A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
US8735586B2 (en) Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
EP2176203B1 (en) A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates
HK1141287A (en) A transition metal catalyzed synthesis of n-aminoindoles
HK1142893A (en) A transition metal catalyzed synthesis of 2h-indazoles
HK1133880A (en) A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130402